Assignee
R PHARM OVERSEAS INC
US·3 granted patents·3 pending applications·1 citations·filing 2014–2024
Top patents by PatentIndex Score
6 records- 0171US10450278B2Substituted 2-thioxo-imidazolidin-4-ones and spiro analogues thereof, active anticancer ingredient, pharmaceutical composition, medicinal preparation, method for treating prostate cancerR PHARM OVERSEAS INC·Filed 2015·Granted Oct 22, 2019·1 cites·19 claims
- 0254US2024307490A1Use of il1-r1 derived inhibitor of il-1b for the treatment of idiopathic recurrent pericarditisR PHARM OVERSEAS INC·Filed 2024·Application pending·0 cites
- 0352US12180264B2IL1-R1 derived inhibitor of IL-1β and use thereofR PHARM OVERSEAS INC·Filed 2021·Granted Dec 31, 2024·0 cites·5 claims
- 0444US11155600B2Human IL1-R1 derived inhibitor of IL-1βR PHARM OVERSEAS INC·Filed 2014·Granted Oct 26, 2021·0 cites·2 claims
- 0535US2017073391A1Osteoprotegerin derived RANKL inhibitorR-PHARM OVERSEAS INC·Filed 2014·Application pending·0 cites
- 0633US2021115143A1Anti-pd-l1 antibody and use thereofR PHARM OVERSEAS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when R PHARM OVERSEAS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →